San Diego, CA, United States of America

Paul Clark Steams

This inventor holds 1 USPTO granted patent. Top assignee: Veroscience LLC. Active years: 2013.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Paul Clark Steams

Introduction

Paul Clark Steams is a notable inventor based in San Diego, California. He has made significant advancements in the pharmaceutical field, particularly focusing on treatments for type 2 diabetes. His dedication to innovation is reflected in his patented work, which aims to improve patients' quality of life through effective medication.

Latest Patents

Steams holds a patent for bromocriptine formulations. The patent details pharmaceutical formulations of bromocriptine mesylate and outlines methods for manufacturing and using these formulations. Specifically, these formulations have proven useful for improving glycemic control in individuals suffering from type 2 diabetes, showcasing Steams' commitment to addressing pressing health issues through his work.

Career Highlights

Throughout his career, Paul Clark Steams has worked with Veroscience LLC, where he has contributed to the development of innovative pharmaceutical solutions. His expertise in the formulation of medications plays a crucial role in advancing therapeutic options for diabetes management.

Collaborations

Steams has collaborated with notable colleagues, including Anthony H. Cincotta and Craig Michael Bowe. These partnerships highlight the importance of teamwork in driving innovation and improving healthcare solutions. Through collaborative efforts, they work to enhance the efficacy of treatments available for diabetes patients.

Conclusion

In summary, Paul Clark Steams is a dedicated inventor whose work in the development of bromocriptine formulations represents a significant contribution to pharmaceutical innovations. His collaboration with skilled professionals at Veroscience LLC and his focus on improving glycemic control in type 2 diabetes underscore his commitment to enhancing medical treatments and patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…